Tocilizumab for Systemic Juvenile Idiopathic Arthritis Reply

被引：12
|
作者：
De Benedetti, Fabrizio [1 ]
机构：
[1] Osped Pediat Bambino Gesu, Rome, Italy
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 13期
关键词：
MACROPHAGE ACTIVATION SYNDROME; INTERLEUKIN-6;
D O I：
10.1056/NEJMc1301017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1256 / 1257
页数：2
相关论文
共 50 条
  • [21] Tocilizumab for treating juvenile idiopathic arthritis
    Turnier, Jessica L.
    Brunner, Hermine I.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (04) : 559 - 566
  • [22] OUTCOME OF TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Balameena, S.
    Ravichandran, R.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (23): : 2746 - 2748
  • [23] PHARMACOECONOMIC EVALUATION OF TREATMENT WITH TOCILIZUMAB IN RUSSIAN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Ryazhenov, V. V.
    Gorokhova, S. G.
    Emchenko, I., V
    VALUE IN HEALTH, 2014, 17 (07) : A380 - A380
  • [24] COST-UTILITY OF TOCILIZUMAB IN THE TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN FINLAND
    Hallinen, T.
    Soini, E. J.
    Diamantopoulos, A.
    Dejonckheere, F.
    Vihervaara, V.
    Hautala, A.
    Aalto, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 258 - 259
  • [25] Tocilizumab Use in Pediatrics With Systemic Juvenile Idiopathic Arthritis: Single Center Data
    Jain, Swati
    Bernhardt, M. Brooke
    Ramirez, Andrea A.
    Sagcal-Gironella, Anna Carmela
    de Guzman, Marietta
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 62 - 64
  • [26] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Systemic Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Ruperto, Nicola
    Lovell, Daniel J.
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Hsu, Joy
    Bao, Min
    Douglass, Wendy
    Mallalieu, Navita L.
    Wells, Chris
    Mala, Christopher M.
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [27] Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
    Zhang, Ye
    Ru, Jinli
    Zhang, Jinxiu
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 293 - 300
  • [28] Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
    Fabrizio De Benedetti
    Rayfel Schneider
    Sheila Weitzman
    Clare Devlin
    Kaori Daimaru
    Shumpei Yokota
    Syuji Takei
    Angelo Ravelli
    Pediatric Rheumatology, 12 (Suppl 1)
  • [29] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Takako Miyamae
    Tomoyuki Imagawa
    Shigeki Katakura
    Rumiko Kurosawa
    Masaaki Mori
    Clinical Reviews in Allergy & Immunology, 2005, 28 : 231 - 237
  • [30] Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
    Maria I Kaleda
    Irina Nikishina
    Svetlana Rodionovskaya
    Anna Shapovalenko
    Pediatric Rheumatology, 12 (Suppl 1)
12345